MAP2K1 GENE MUTATION

Clinical trials for MAP2K1 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new MAP2K1 GENE MUTATION trials appear

Sign up with your email to follow new studies for MAP2K1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for advanced colon cancer patients who stopped responding to standard treatments

Disease control Ongoing

This study tests two drugs, panitumumab and trametinib, in 59 people with stage IV colorectal cancer that no longer responds to standard therapies. Panitumumab helps the immune system attack cancer cells, while trametinib blocks enzymes that help tumors grow. The goal is to see i…

Matched conditions: MAP2K1 GENE MUTATION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

MAP2K1 GENE MUTATION

Get alerted when new MAP2K1 GENE MUTATION trials appear

New hope for advanced colon cancer patients who stopped responding to standard treatments